Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 175

Similar articles for PubMed (Select 21818622)

1.

Early effects of erythropoietin on serum hepcidin and serum iron bioavailability in healthy volunteers.

Lainé F, Laviolle B, Ropert M, Bouguen G, Morcet J, Hamon C, Massart C, Westermann M, Deugnier Y, Loréal O.

Eur J Appl Physiol. 2012 Apr;112(4):1391-7. doi: 10.1007/s00421-011-2097-7. Epub 2011 Aug 5.

PMID:
21818622
2.

Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.

Shoji S, Inaba M, Tomosugi N, Okuno S, Ichii M, Yamakawa T, Kurihara S.

Eur J Haematol. 2013 Mar;90(3):237-44. doi: 10.1111/ejh.12067.

PMID:
23281632
3.

Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.

Mittman N, Sreedhara R, Mushnick R, Chattopadhyay J, Zelmanovic D, Vaseghi M, Avram MM.

Am J Kidney Dis. 1997 Dec;30(6):912-22.

PMID:
9398141
4.

Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy.

Finkenstedt A, Widschwendter A, Brasse-Lagnel CG, Theurl I, Hubalek M, Dieplinger H, Tselepis C, Ward DG, Vogel W, Zoller H.

Blood Cells Mol Dis. 2012 Apr 15;48(4):233-7. doi: 10.1016/j.bcmd.2012.02.001. Epub 2012 Feb 25.

PMID:
22365732
5.

Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients.

Kato A, Tsuji T, Luo J, Sakao Y, Yasuda H, Hishida A.

Am J Nephrol. 2008;28(1):115-21. Epub 2007 Oct 17.

PMID:
17943020
6.

Effects of iron supplementation on serum hepcidin and serum erythropoietin in low-birth-weight infants.

Berglund S, Lönnerdal B, Westrup B, Domellöf M.

Am J Clin Nutr. 2011 Dec;94(6):1553-61. doi: 10.3945/ajcn.111.013938. Epub 2011 Nov 9.

7.

Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children.

Aeberli I, Hurrell RF, Zimmermann MB.

Int J Obes (Lond). 2009 Oct;33(10):1111-7. doi: 10.1038/ijo.2009.146. Epub 2009 Jul 28.

PMID:
19636315
8.

Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin.

Robach P, Recalcati S, Girelli D, Campostrini N, Kempf T, Wollert KC, Corbella M, Santambrogio P, Perbellini L, Brasse-Lagnel C, Christensen B, Moutereau S, Lundby C, Cairo G.

Eur J Haematol. 2013 Jul;91(1):74-84. doi: 10.1111/ejh.12122. Epub 2013 May 3.

PMID:
23582009
9.

Effect of erythropoietin on hepcidin, DMT1 with IRE, and hephaestin gene expression in duodenum of rats.

Kong WN, Chang YZ, Wang SM, Zhai XL, Shang JX, Li LX, Duan XL.

J Gastroenterol. 2008;43(2):136-43. doi: 10.1007/s00535-007-2138-5. Epub 2008 Feb 29.

PMID:
18306987
10.

Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjects.

Olsson-Gisleskog P, Jacqmin P, Perez-Ruixo JJ.

Clin Pharmacokinet. 2007;46(2):159-73.

PMID:
17253886
11.

[The effect of tobacco smoking during pregnancy on concentration of pro-hepcidin and some parameters of iron metabolism in matched-maternal cord pairs].

Chełchowska M, Lewandowski L, Ambroszkiewicz J, Swiatek E, Gajewska J, Ołtarzewski M, Laskowska-Klita T.

Przegl Lek. 2008;65(10):474-8. Polish.

PMID:
19189526
12.

Randomized, double-blind, placebo-controlled trial of an iron-fortified food product in female soldiers during military training: relations between iron status, serum hepcidin, and inflammation.

Karl JP, Lieberman HR, Cable SJ, Williams KW, Young AJ, McClung JP.

Am J Clin Nutr. 2010 Jul;92(1):93-100. doi: 10.3945/ajcn.2010.29185. Epub 2010 May 5.

13.

Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.

Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, Ganz T, Rivera S, Nissenson AR, Salusky IB.

Clin J Am Soc Nephrol. 2009 Jun;4(6):1051-6. doi: 10.2215/CJN.05931108. Epub 2009 Apr 30.

14.

Subcutaneous versus intravenous administration of erythropoietin improves its efficiency for the treatment of anaemia in haemodialysis patients.

Albitar S, Meulders Q, Hammoud H, Soutif C, Bouvier P, Pollini J.

Nephrol Dial Transplant. 1995;10 Suppl 6:40-3.

PMID:
8524493
15.

Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.

Shinzato T, Abe K, Furusu A, Harada T, Shinzato K, Miyazaki M, Kohno S.

Med Sci Monit. 2008 Sep;14(9):CR431-7.

PMID:
18758412
16.

Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.

Sangwaiya A, Manglam V, Busbridge M, Thursz M, Arnold J.

Eur J Gastroenterol Hepatol. 2011 Aug;23(8):721-4. doi: 10.1097/MEG.0b013e3283484716.

PMID:
21654321
17.

Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy.

Malyszko J, Malyszko JS, Mysliwiec M.

Kidney Blood Press Res. 2009;32(4):235-8. doi: 10.1159/000235747. Epub 2009 Aug 21.

PMID:
19713706
18.

Reproducibility of and correspondence among different hepcidin forms in blood and urine and their relationships to iron status in healthy, male Guatemalan volunteers observed over 9 weeks.

Schuemann K, Solomons NW, Laarakkers CM, Romero-Abal ME, Kroll S, Weiss G, Swinkels DW.

Ann Nutr Metab. 2011;58(2):158-66. doi: 10.1159/000327913. Epub 2011 Jun 8.

PMID:
21654163
19.

Serum hepcidin in haemodialysis patients: associations with iron status and microinflammation.

Xu Y, Ding XQ, Zou JZ, Liu ZH, Jiang SH, Chen YM.

J Int Med Res. 2011;39(5):1961-7.

PMID:
22118000
20.

[Serum prohepcidin and other iron metabolism parameters in healthy adults].

Zekanowska E, Boinska J, Kwapisz J, Kedziora-Kornatowska K, Porzych K, Ratajczak M.

Przegl Lek. 2011;68(2):82-6. Polish.

PMID:
21751515
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk